New pacing method cuts cardiac risk 59%

• by Teraya Smith

• November 11, 2026

Roxadustat Treatment After PCI Among Patients With ST-Segment Elevation Myocardial Infarction: A Randomized

• by Weiwei Quan, Yueying Wang, Min Zhang, Tianqi Zhu, Jinzhou Zhu, Xiaoqun Wang, Zhengbin Zhu, Run Du, Fenghua Ding, Jingwei Ni, Shuo Feng, Hongyang Xie, Lili Liu, Yuehua Fang, Xuezheng Qu, Ruiyan Zhang, Xiaoxiang Yan

• October 9, 2026

Are Patients Being Referred to Heart Failure Specialists Too Late?

For patients who exhibit common heart failure symptoms and don’t respond to medical therapy, it’s never too early to consider a referral, a Keck Medicine of USC cardiac surgeon advises.

• by

• September 25, 2026

• 5 min

Sacubitril/Valsartan Versus Angiotensin-Converting Enzyme Inhibitor/Angiotensin Receptor Blocker Across the Ejection Fraction Spectrum: A Multistate Real-World Cohort

• by MICHEL CHEDID EL HELOU, KARIM HOYEK, HARSH PATOLIA, MICHAEL HILL, ZIAD ZALAQUETT, HUNTER BLOCK-BEACH, ASHISH SARRAJU, AMANDA R. VEST, NANCY M. ALBERT, RANDALL C. STARLING, TREJEEVE MARTYN

• October 10, 2026